Animal Health

Providing Expertise and Experience in Customized Solutions

MRIGlobal has 55 years of experience providing solutions to trailblazing animal health companies, including safety testing, custom animal models, bioequivalence studies, and biomarker development.

  • Target Animal Safety Studies
  • Specialty Animal Models
  • Bioanalytical
  • Animal Diagnostics
  • Bioequivalence

Contact

Robert Casillas, Ph.D.
816-401-7783

Request Information

Distinct Capabilities

pig-04

Specialty Animal Models

  • Diabetes
  • Chronic Renal Failure
  • Wound Healing
  • Skin Infections
  • Rabies

Infectious Disease and Pathogen Capacity

MRIGlobal is uniquely qualified to perform vaccine challenge and infectious disease pathogen evaluation. Our BSL-3 containment facility has the capacity to handle pathogens like Avian Influenza, Bacillus anthracis, Brucella melitensis, and Coxiella burnetii.

Expertise and Experience

Animal Health and Toxicology

MRIGlobal has extensive experience in conducting target animal safety studies in a variety of animal species.

  • Efficacy studies
  • Margin of safety in the target animal
    • Drug residues
    • Total residue and metabolism study
    • Tissue residue deleption
  • Bioequivalence studies
  • Pilot dose escalation studies
  • Tolerance studies
    • Acute administration
    • Maximum tolerated dose (MTD) studies
  • Toxicity studies
  • Residue determination after topical applications
  • Special studies
    • Comparative effectiveness

Facilites

AAALAC accredited and USDA and DHHS-OLAW approved animal care facilities capable of housing multiple species, including companion animals. In addition to conventional facilities, maintain several biocontainment facilities (ABSL2, ABSL3) additionally approved by the CDC, which can be used when restricted biological organisms are required for MCM efficacy testing.

Techniplast caging for optimal animal health and collection efficiency plus protection against cross-contamination.

Quality Assurance for Every Project

We understand that consistently delivering high quality outcomes is imperative. MRIGlobal out-performs our competition in meeting those high expectations on every project.

Our Quality assurance program, independently operated within MRIGlobal, ensures that MRIGlobal not only meets but exceeds client-specific QA requirements including but not limited to:

  • ISO 9001:2008
  • FDA GLP, cGMP
  • EPA FIFRA GLP

Excellence in Project Management

MRIGlobal works with a wide variety of Study Sponsors, providing beginning to end support for each study.  Regulatory compliance, study management, and data reporting are an integral part of every study and include GLP, CVM guidelines, USDA OPPTS, Study Protocol, IACUC approval of protocols, statistics, a communication schedule, timelines/milestones/metrics, automated data capture, QA audited reports (GLP studies), and on-line sponsor data sharing.